Trial Profile
A retrospective study of effect of treatment with dupilumab on depressive symptoms in a cohort of patients with asthma with eosinophilic chronic rhinosinusitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 May 2022
Price :
$35
*
At a glance
- Drugs Dupilumab (Primary)
- Indications Asthma; Depression; Rhinosinusitis
- Focus Therapeutic Use
- 17 May 2022 New trial record